We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Canada is yet to act on legislation it passed two years ago to enable the supply of affordable anti-AIDS drugs to Africa, according to international organization Medecins Sans Frontieres (MSF).
The International Vaccine Institute (IVI) has received $21 million in funding from the Bill & Melinda Gates Foundation for a cholera vaccine initiative, which will include conducting further clinical trials of CholeraGarde, Avant Immunotherapeutics' cholera vaccine.
The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) and Pfizer have issued a recall of Lipitor 20-mg tablets bearing the lot number 067404K3 for being counterfeit.
Japanese drugmaker Eisai has filed a lawsuit against United Research Laboratories and Mutual Pharmaceutical regarding the submission of an abbreviated new drug application to the FDA for Aricept Orally Disintegrating Tablets (donepezil HCl).
Tokyo-based medical instrument developer/ distributor, Fukuda Denshi intends to sell France-based Kontron Medical SAS and Switzerland-based Kontron Medical AG by the end of 2006.
Granules India Ltd. and Amneal Pharmaceuticals LLC (United States) are pleased to announce the approval of the ANDA of Metformin Hydrochloride tablets of 500 mg, 850 mg and 1000 mg.
Tokyo-based Daiichi Sankyo Company, a wholly owned subsidiary of Daiichi Sankyo Company, Limited and its US subsidiary has commenced litigation against Mylan Pharmaceuticals in the United States District Court for the District of New Jersey for infringement of Sankyo's US patent covering olmesartan medoxomil, the active ingredient in Sankyo's antihypertensive drug -- Benicar.
Just as storm clouds were forming above Biovail Corp. and its enigmatic chairman, the drug maker was hit with a downpour Wednesday, losing a patent infringement case that opens the door for a cheaper generic copy of its best-selling antidepressant Wellbutrin XL.
Country's biggest drug maker, Ranbaxy Laboratories Ltd on Thursday said a US Appeals Court has ruled in its favour in the patent infringement case with Pfizer for cholesterol-lowering drug Atorvastatin (Lipitor).